First person – Matt Johansen
First Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms, helping early-career researchers promote themselves alongside their papers. Matt Johansen is first author on ‘ Mycobacteriophage–antibiotic therapy promotes enhanced c...
| Format: | Article |
|---|---|
| Language: | English |
| Published: |
The Company of Biologists
2021-09-01
|
| Series: | Disease Models & Mechanisms |
| Online Access: | http://dmm.biologists.org/content/14/9/dmm049238 |
| _version_ | 1818458794715250688 |
|---|---|
| collection | DOAJ |
| description | First Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms, helping early-career researchers promote themselves alongside their papers. Matt Johansen is first author on ‘
Mycobacteriophage–antibiotic therapy promotes enhanced clearance of drug-resistant Mycobacterium abscessus’, published in DMM. Matt completed the research described in this article while a postdoc in the lab of Laurent Kremer at Institut de Recherche en Infectiologie de Montpellier, Montpellier, France, and is now a postdoc in the lab of Phil Hansbro at the Centre for Inflammation, Centenary Institute and University of Technology Sydney, Sydney, Australia, investigating the disease pathogenesis of infectious organisms and deciphering host–pathogen interactions. |
| first_indexed | 2024-12-14T23:04:07Z |
| format | Article |
| id | doaj.art-26f986365e5d431a849b26e2b50335a6 |
| institution | Directory Open Access Journal |
| issn | 1754-8403 1754-8411 |
| language | English |
| last_indexed | 2024-12-14T23:04:07Z |
| publishDate | 2021-09-01 |
| publisher | The Company of Biologists |
| record_format | Article |
| series | Disease Models & Mechanisms |
| spelling | doaj.art-26f986365e5d431a849b26e2b50335a62022-12-21T22:44:23ZengThe Company of BiologistsDisease Models & Mechanisms1754-84031754-84112021-09-0114910.1242/dmm.049238049238First person – Matt JohansenFirst Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms, helping early-career researchers promote themselves alongside their papers. Matt Johansen is first author on ‘ Mycobacteriophage–antibiotic therapy promotes enhanced clearance of drug-resistant Mycobacterium abscessus’, published in DMM. Matt completed the research described in this article while a postdoc in the lab of Laurent Kremer at Institut de Recherche en Infectiologie de Montpellier, Montpellier, France, and is now a postdoc in the lab of Phil Hansbro at the Centre for Inflammation, Centenary Institute and University of Technology Sydney, Sydney, Australia, investigating the disease pathogenesis of infectious organisms and deciphering host–pathogen interactions.http://dmm.biologists.org/content/14/9/dmm049238 |
| spellingShingle | First person – Matt Johansen Disease Models & Mechanisms |
| title | First person – Matt Johansen |
| title_full | First person – Matt Johansen |
| title_fullStr | First person – Matt Johansen |
| title_full_unstemmed | First person – Matt Johansen |
| title_short | First person – Matt Johansen |
| title_sort | first person matt johansen |
| url | http://dmm.biologists.org/content/14/9/dmm049238 |